Institutional Review Board At Clinical Pharmacology Of Miami Approves MetaVia Phase 1 Part 3 Clinical Trial Of DA-1726.

Benzinga Newsdesk www.benzinga.com Positive 62.3%

Neg 0% Neu 0% Pos 62.3%

16-Week Study to Evaluate One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults